Role of Iterative Normothermic Intraperitoneal Paclitaxel Combined with Systemic Chemotherapy in the Management of Gastric Peritoneal Carcinomatosis

被引：0
|
作者：
Maheswari Senthil
Farshid Dayyani
机构：
[1] University of California-Irvine,Division of Surgical Oncology
[2] University of California-Irvine,Division of Hematology and Oncology
来源：
Annals of Surgical Oncology | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：694 / 696
页数：2
相关论文
共 50 条
  • [1] Role of Iterative Normothermic Intraperitoneal Paclitaxel Combined with Systemic Chemotherapy in the Management of Gastric Peritoneal Carcinomatosis
    Senthil, Maheswari
    Dayyani, Farshid
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (02) : 694 - 696
  • [2] Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis
    Tajik, Fatemeh
    Eyob, Belain
    Khan, Aaqil M.
    Radhakrishnan, Vinodh Kumar
    Senthil, Maheswari
    CANCERS, 2025, 17 (02)
  • [3] Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis
    Nakashima, Taiki
    Arigami, Takaaki
    Uenosono, Yoshikazu
    Matsushita, Daisuke
    Shimonosono, Masataka
    Tsuruda, Yusuke
    Sasaki, Ken
    Baba, Kenji
    Kurahara, Hiroshi
    Ohtsuka, Takao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (10) : 1371 - 1377
  • [4] Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis
    Taiki Nakashima
    Takaaki Arigami
    Yoshikazu Uenosono
    Daisuke Matsushita
    Masataka Shimonosono
    Yusuke Tsuruda
    Ken Sasaki
    Kenji Baba
    Hiroshi Kurahara
    Takao Ohtsuka
    International Journal of Clinical Oncology, 2023, 28 : 1371 - 1377
  • [5] Peritoneal carcinomatosis from colorectal cancer: hyperthermic intraperitoneal chemotherapy and the role of systemic chemotherapy
    Michael, Michael
    COLORECTAL CANCER, 2013, 2 (05) : 449 - 457
  • [6] Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial
    Maheswari Senthil
    Farshid Dayyani
    BMC Cancer, 23
  • [7] Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial
    Murono, Koji
    Nagata, Hiroshi
    Ishimaru, Kazuhiro
    Emoto, Shigenobu
    Kaneko, Manabu
    Hiyoshi, Masaya
    Sasaki, Kazuhito
    Otani, Kensuke
    Shuno, Yasutaka
    Nishikawa, Takeshi
    Tanaka, Toshiaki
    Hata, Keisuke
    Kawai, Kazushige
    Nozawa, Hiroaki
    Muro, Kei
    Ishihara, Soichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (01) : 145 - 150
  • [8] Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial
    Koji Murono
    Hiroshi Nagata
    Kazuhiro Ishimaru
    Shigenobu Emoto
    Manabu Kaneko
    Masaya Hiyoshi
    Kazuhito Sasaki
    Kensuke Otani
    Yasutaka Shuno
    Takeshi Nishikawa
    Toshiaki Tanaka
    Keisuke Hata
    Kazushige Kawai
    Hiroaki Nozawa
    Kei Muro
    Soichiro Ishihara
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 145 - 150
  • [9] Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis
    Rihuete Caro, Cristina
    Manzanedo, Israel
    Pereira, Fernando
    Carrion-Alvarez, Lucia
    Serrano, Angel
    Perez-Viejo, Estibalitz
    EJSO, 2018, 44 (11): : 1805 - 1810
  • [10] Sintilimab combined neoadjuvant intraperitoneal and systemic chemotherapy in gastric cancer with peritoneal metastasis
    Yuan, Hong
    Lu, Sheng
    Shi, Min
    Yang, Zhongyin
    Liu, Wentao
    Ni, Zhentian
    Yao, Xuexin
    Hua, Zichen
    Feng, Runhua
    Zheng, Yanan
    Wang, Zhenqiang
    Sah, Birendra Kumar
    Chen, Mingmin
    Zhu, Zhenglun
    He, Changyu
    Li, Chen
    Zhang, Jun
    Yan, Chao
    Yan, Min
    Zhu, Zhenggang
    FUTURE ONCOLOGY, 2023, 19 (38) : 2517 - 2523
12345